Kenvue Showcases Consumer Health Commitment at 2025 CAGNY Conference

Kenvue’s Commitment to Consumer Health Takes Center Stage at Upcoming CAGNY Conference

Kenvue Inc., recognized as the world's largest pure-play consumer health company by revenue, prepares to engage with industry analysts and investors at the upcoming Consumer Analyst Group of New York (CAGNY) Conference. Scheduled for February 19, 2025, at 3:00 p.m. Eastern Time, the event will feature key executives, including CEO Thibaut Mongon, CFO Paul Ruh, and Chief Growth Officer Charmaine England. Their presentation aims to showcase Kenvue's strategic direction and growth initiatives, reinforcing the company's commitment to innovation and consumer health.

With a history spanning over a century, Kenvue proudly offers an extensive portfolio of trusted brands such as Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, and Tylenol®. These products, which enjoy global recognition, are not only backed by rigorous scientific research but also recommended by healthcare professionals. Kenvue’s focus extends beyond mere product offerings; it emphasizes the importance of everyday care for families, striving to empower consumers through reliable and effective health solutions. This approach positions Kenvue as a household name, reflecting its mission to occupy a special place in the lives of its customers.

The CAGNY presentation serves as a crucial platform for Kenvue to articulate its vision for future growth and innovation in the consumer health sector. By engaging directly with analysts and investors, Kenvue underscores its proactive stance in the marketplace, aiming to build transparency and trust within the investment community. The webcast of the event, along with a subsequent replay, ensures that stakeholders can access valuable insights into the company’s strategic initiatives and product development plans.

Beyond the conference, Kenvue remains dedicated to enhancing consumer awareness of its expansive product range. The company invites interested parties to explore its official website, where they can learn more about Kenvue's commitment to quality and consumer health. As it continues to innovate and adapt to the evolving needs of consumers, Kenvue positions itself as a leader in the industry, reinforcing its legacy of trust and reliability.

Kenvue’s participation in the CAGNY Conference not only highlights its ongoing engagement with investors but also showcases its strategic focus on the consumer health landscape. As the company prepares for this significant event, it underscores its resolve to remain a frontrunner in delivering health solutions that resonate with consumers globally.